Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Jac-Antimicrobial Resistance|January 6, 2022
Sub-growth-inhibitory concentrations of omadacycline inhibit Staphylococcus aureus haemolytic activity in vitroAlisa W Serio, S Ken Tanaka, Kelly Wright, et al.
The Lancet. Infectious Diseases|September 3, 2019
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trialWilliam O'Riordan, Carrie Cardenas, Elliot Shin, et al.
The Journal of Clinical Investigation|January 20, 2007
The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulencePriya Balachandran, Leonard Dragone, Lynne Garrity-Ryan, et al.
The New England Journal of Medicine|February 7, 2019
Omadacycline for Acute Bacterial Skin and Skin-Structure InfectionsWilliam O'Riordan, Sinikka Green, J Scott Overcash, et al.
The New England Journal of Medicine|February 7, 2019
Omadacycline for Community-Acquired Bacterial PneumoniaRoman Stets, Monica Popescu, Joven R Gonong, et al.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose RegimensLu Ann Bundrant, Evan Tzanis, Lynne Garrity-Ryan, et al.
International Journal of Antimicrobial Agents|December 16, 2020
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairmentOliver A Cornely, Thomas M File, Lynne Garrity-Ryan, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2017
Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal FunctionJolene K Berg, Evan Tzanis, Lynne Garrity-Ryan, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b StudyJ Scott Overcash, Pouru Bhiwandi, Lynne Garrity-Ryan, et al.
Future Microbiology|August 20, 2016
Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infectionsStephen Villano, Judith Steenbergen, Evan Loh
Pageof 4